Search
for
Sort by
Research 61–90 of 1000+
- Targets to treat androgen excess in polycystic ovary syndrome
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Ottawa, Ontario, Canada, February 13–16, 2013
- Emerging medication for the treatment of male hypogonadism
- Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health
- An overview on 5α-reductase inhibitors
- Childhood onset trichotillomania: a retrospective analysis of 78 cases visiting tertiary general hospital
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Niosomes as Carrier in Dermal Drug Delivery
- Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
- Psychotropic Treatment of Psychodermatologic Disorders
- Trichotillomania in Childhood: A Case Report
- Estrogens and aging skin
- Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Psychocutaneous disease
- Psychodermatology
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Obsessive-compulsive disorder in dermatology
- Beneath the surface: dermatology and psychiatry
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- miR-29a-5p Inhibits Prenatal Hair Placode Formation Through Targeting EDAR by ceRNA Regulatory Network
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias
- The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year